41st Annual Meeting of the European Association for the Study of Diabetes, Athens Obesity is a major determinant of the association of C-reactive protein levels with the number of metabolic syndrome components in recently diagnosed, drug-naive type 2 diabetes: the ADOPT study cohort
Kahn SE, Zinman B, Viberti G, Kravitz BG, Yu D, Heise MA, Freed MI, the ADOPT Study Group
Diabetologia 2005;48:suppl 1:A249 [Abstract]
41st Annual Meeting of the European Association for the Study of Diabetes, Athens BMI and ratio of triglycerides to HDL are most predictive of insulin resistance in a drug naive population with type 2 diabetes
Patwardhan R, Lin X, Zambanini A, Eslava S, the ADOPT Study Group
Diabetologia 2005;48:suppl 1:A222 [Abstract]
65th Scientific Sessions of the American Diabetes Association, San Diego Hepatic enzymes are associated with insulin resistance and impaired fibrinolysis in drug naïve, recently diagnosed type 2 diabetes subjects
Haffner SM, Kahn SE, Heise MA, O'Neill MC, Zinman B, the ADOPT Study Group
Diabetes 2005;54:suppl 1:A255 [Abstract]
65th Scientific Sessions of the American Diabetes Association, San Diego Obesity is a major determinant of the association of C-reactive protein levels with the number of metabolic syndrome components in type 2 diabetes
Kahn SE, Zinman B, Viberti G, Kravitz BG, Yu D, Heise MA, Freed MI, the ADOPT Study Group
Diabetes 2005;54:suppl 1:A255 [Abstract]
65th Scientific Sessions of the American Diabetes Association, San Diego A Cardiovascular Risk Calculator for Type 2 Diabetes
Coleman RL, Stevens RJ, Matthews DR, Holman RR
Diabetes 2005;54:Suppl 1:A172
41st Annual Meeting of the European Association for the Study of Diabetes, Athens Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
Coleman RL, Stevens RJ, Holman RR
Diabetologia 2005;48:Suppl 1:A32
41st Annual Meeting of the European Association for the Study of Diabetes, Athens FPG and HbA1c are independent risk factors for microvascular but not macrovascular complications in newly diagnosed type 2 diabetes
Kim JI, Stevens RJ, Holman RR
Diabetologia 2005;48:Suppl 1:A33 [Abstract]
41st Annual Meeting of the European Association for the Study of Diabetes, Athens Susceptibility for latent autoimmune diabetes in adults (LADA) is determined by variation at the IDDM2 (insulin-gene) locus in white Caucasian patients from UK repositories
Desai M, Zeggini E, Owen KR, Holman RR, Levy JC, Hattersley AT, Hitman GA, Walker M, McCarthy MI, Clark A
Diabetologia 2005;48:Suppl1:A86 [Abstract]
41st Annual Meeting of the European Association for the Study of Diabetes, Athens Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS
Clark A, Desai M, Cull CA, Horton VA, Christie MR, Bingley PJ, Bonifacio E, Levy JC, Holman RR
Diabetologia 2005;48:Suppl 1:A86 [Abstract]
41st Annual Meeting of the European Association for the Study of Diabetes, Athens Genotype and beta cell response to therapy in a large type 2 diabetic cohort
Powell BL, Stratton IM, Holman RR, McCarthy MI
Diabetologia 2005;48:Suppl 1:A101-A102 [Abstract]
Diabetes UK Annual Professional Conference, Glasgow AFORRD: a multi-centre trial evaluating potential cardiovascular risk reduction in patients with type 2 diabetes randomised in a factorial design to atorvastatin and/or omega-3 polyunsaturated fatty acids
Farmer AJ,Neil HAW, Holman RR
Diabetic Medicine 2005;22:S2:63 [Abstract]
Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ
Tel: +44 (0)1865 857242 Email: dtu@dtu.ox.ac.uk